DEFB108A
Putative beta-defensin 108A
Also known as: DB108_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for DEFB108A in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
73 residues, UniProt reviewed canonical sequence.
>A8MXU0|DEFB108A
1 MRIAVLFFTI FFFMSQVLPA KGKFKEICER PNGSCRDFCL ETEIHVGRCL NSRPCCLPLG
61 HQPRIESTTP KKDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DEFB108A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DEFB108A as an antibody target. Whether an autoantibody or antibody against DEFB108A could matter depends on whether native DEFB108A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DEFB108A is annotated as secreted, so native DEFB108A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label DEFB108A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...